Full View

Metabolic dyslipidemia and cardiovascular outcomes in type 2 diabetes mellitus: findings from the look AHEAD study

AD Kaze, P Santhanam, SK Musani… - Journal of the …, 2021 - Am Heart Assoc
Background Metabolic dyslipidemia (high triglyceride) and low high‐density lipoprotein
cholesterol (HDL‐C) is highly prevalent in type 2 diabetes mellitus (T2DM). The extent to …
被引用次数：76 相关文章

Metabolic dyslipidemia and cardiovascular outcomes in type 2 diabetes mellitus: findings from the look ahead study.

AD Kaze, P Santhanam, SK Musani, R Ahima… - 2021 - cabidigitallibrary.org
Background: Metabolic dyslipidemia (high triglyceride) and low high-density lipoprotein
cholesterol (HDL-C) is highly prevalent in type 2 diabetes mellitus (T2DM). The extent to …

Metabolic Dyslipidemia and Cardiovascular Outcomes in Type 2 Diabetes Mellitus: Findings From the Look AHEAD Study

AD Kaze, P Santhanam, SK Musani, R Ahima… - 2021 - Am Heart Assoc
BACKGROUND: Metabolic dyslipidemia (high triglyceride) and low high-density lipoprotein
cholesterol (HDL-C) is highly prevalent in type 2 diabetes mellitus (T2DM). The extent to …
[PDF] semanticscholar.org

[PDF][PDF] Metabolic Dyslipidemia and Cardiovascular Outcomes in Type 2 Diabetes Mellitus: Findings From the Look AHEAD Study

AD Kaze, P Santhanam, SK Musani, R Ahima… - 2021 - pdfs.semanticscholar.org
BACKGROUND: Metabolic dyslipidemia (high triglyceride) and low high-density lipoprotein
cholesterol (HDL-C) is highly prevalent in type 2 diabetes mellitus (T2DM). The extent to …

Metabolic Dyslipidemia and Cardiovascular Outcomes in Type 2 Diabetes Mellitus: Findings From the Look AHEAD Study

AD Kaze, P Santhanam, SK Musani, R Ahima… - 2021 - pubmed.ncbi.nlm.nih.gov
Background Metabolic dyslipidemia (high triglyceride) and low high-density lipoprotein
cholesterol (HDL-C) is highly prevalent in type 2 diabetes mellitus (T2DM). The extent to …

Metabolic Dyslipidemia and Cardiovascular Outcomes in Type 2 Diabetes Mellitus: Findings From the Look AHEAD Study.

AD Kaze, P Santhanam, SK Musani… - Journal of the …, 2021 - europepmc.org
Background Metabolic dyslipidemia (high triglyceride) and low high-density lipoprotein
cholesterol (HDL-C) is highly prevalent in type 2 diabetes mellitus (T2DM). The extent to …

Metabolic Dyslipidemia and Cardiovascular Outcomes in Type 2 Diabetes Mellitus: Findings From the Look AHEAD Study

AD Kaze, P Santhanam, SK Musani, R Ahima… - Journal of the American …, 2021 - cir.nii.ac.jp
抄録< jats: sec xml: lang=" en">< jats: title> Background</jats: title>< jats: p xml: lang=" en">
Metabolic dyslipidemia (high triglyceride) and low high‐density lipoprotein cholesterol (HDL …

Metabolic dyslipidemia and cardiovascular outcomes in type 2 diabetes mellitus: Findings from the look ahead study

AD Kaze, P Santhanam, SK Musani… - Journal of the …, 2021 - pure.johnshopkins.edu
BACKGROUND: Metabolic dyslipidemia (high triglyceride) and low high-density lipoprotein
cholesterol (HDL-C) is highly prevalent in type 2 diabetes mellitus (T2DM). The extent to …
[HTML] nih.gov

[HTML][HTML] Metabolic Dyslipidemia and Cardiovascular Outcomes in Type 2 Diabetes Mellitus: Findings From the Look AHEAD Study

AD Kaze, P Santhanam, SK Musani… - Journal of the …, 2021 - ncbi.nlm.nih.gov
Background Metabolic dyslipidemia (high triglyceride) and low high‐density lipoprotein
cholesterol (HDL‐C) is highly prevalent in type 2 diabetes mellitus (T2DM). The extent to …

Metabolic Dyslipidemia and Cardiovascular Outcomes in Type 2 Diabetes Mellitus: Findings From the Look AHEAD Study.

AD Kaze, P Santhanam, SK Musani… - Journal of the …, 2021 - europepmc.org
Background Metabolic dyslipidemia (high triglyceride) and low high-density lipoprotein
cholesterol (HDL-C) is highly prevalent in type 2 diabetes mellitus (T2DM). The extent to …